Related Experiment Video
Updated: Jun 15, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Injecting illicit substances epidemic and infective endocarditis
Ioannis Starakis1, Elias E Mazokopakis
1Internal Medicine Department, Patras University Hospital, Rion-Patras, Greece. istarakis@yahoo.com
Infective endocarditis (IE) is a serious concern for intravenous drug abusers (IVDAs). This review comprehensively covers IE in IVDAs, focusing on epidemiology, diagnosis, and treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Infective endocarditis (IE) is a critical concern in intravenous drug abusers (IVDAs).
- While historically associated with right-sided heart valves, left-sided IE is increasingly reported in this population.
- Despite advances in imaging, understanding right-sided IE in IVDAs requires further attention.
Purpose of the Study:
- To comprehensively review the epidemiology, predisposing factors, clinical features, complications, diagnosis, treatment, and prognosis of IE in IVDAs.
- To highlight distinctive and exclusive features of IE in individuals who inject illicit substances.
- To provide an updated perspective on this serious condition.
Main Methods:
- Literature review of published reports on IE in IVDAs.
- Synthesis of information regarding epidemiological trends.
- Analysis of clinical presentations, diagnostic modalities, and therapeutic strategies.
Main Results:
- Right-sided endocarditis constitutes approximately 10% of all IE cases and is strongly linked to illicit drug injection.
- An increasing trend of left-sided valve involvement in IE among IVDAs has been observed.
- Despite improved diagnostic capabilities, challenges remain in fully understanding right-sided IE.
Conclusions:
- IE remains a significant risk for IVDAs, necessitating high clinical suspicion.
- The evolving patterns of IE, including increased left-sided valve involvement, require ongoing vigilance.
- A comprehensive understanding and tailored management approach are crucial for improving outcomes in this patient group.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Myocarditis I: Introduction

